Brand Story
06 Jun 2023, 00:13 GMT+10
Worldwide sales of clinical trial imaging devices are predicted to increase at a CAGR of 6.5% from 2023 to 2033. The global clinical trial imaging market is currently valued at US$ 1.15 billion and is thus projected to reach US$ 2.17 billion by the end of the forecast period. The clinical trial imaging market refers to the use of imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), in clinical trials to diagnose and monitor the progress of diseases or conditions being studied.
The need for imaging technologies in clinical trials is predicted to rise in the upcoming years, driven by the rising frequency of chronic illnesses and the demand for more precise and effective diagnostic equipment. The industry is also anticipated to gain from technological advancements and the creation of fresh imaging methods. By service type, modality, and end-user, the market is also divided into segments. Trial design and consulting, operational imaging services, and software and system development are examples of service categories. MRI, CT, PET, among other modalities, are examples. Pharmaceutical and biotechnology firms, contract research organisations (CROs), as well as academic and research organisations, are among the end consumers of clinical trial imaging services.
Download Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=8259
Key Segments of Clinical Trial Imaging Industry Research
Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=8259
Key Takeaways from Market Study
Competitive Landscape
Key Companies Profiled
Winning Strategy
Key manufacturers of clinical trial imaging solutions are adopting new tactics to improve business operations and profitability through the creation of new products and partnerships with other market participants. The strategic actions taken by these market participants, such as new product launches, conferences, and acquisitions, help them expand and enhance their company's product range, which in turn is increasing revenue share.
For in-depth competitive analysis, Buy Now - https://www.factmr.com/checkout/8259
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global clinical trial imaging market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.
The study divulges essential insights on the market on the basis of service (project & data management, operational imaging services, reading & analytical services, clinical trial design & consultation services, system & technology support services), application (non-alcoholic steatohepatitis, oncology, neurology, endocrinology, cardiology, dermatology, hematology), and end user (contract research organizations, biotechnology & pharmaceutical companies, medical devices manufacturers, academic & government research institutes), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Contact:
US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
Vancouver, Canada: A high-stakes legal showdown is brewing in the world of athleisure. Lululemon, the Canadian brand known for its...
LONDON, U.K.: British oil giant Shell has denied reports that it is in talks to acquire rival oil company BP. The Wall Street Journal...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...
ABU DHABI, 19th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has become the first and only research hospital in the UAE to receive...
ABU DHABI, 17th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...
ABU DHABI,16th May, 2025 (WAM) - Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking...
ABU DHABI, 6th May, 2025 (WAM) -- PureHealth and its subsidiary SEHA have partnered with the number one US children's hospital, Cincinnati...
Argentinian composer Lalo Schifrin, the genre-blending film and television composer behind the Mission: Impossible, Bullitt, and Cool...